| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/09/2023 | 11.94% | Goldman Sachs | $3 → $1.5 | Maintains | Neutral |
| 11/02/2023 | 11.94% | UBS | $2.5 → $1.5 | Maintains | Neutral |
| 09/05/2023 | 34.33% | Morgan Stanley | $2.5 → $1.8 | Maintains | Underweight |
| 08/17/2023 | 67.91% | RBC Capital | $2.75 → $2.25 | Maintains | Sector Perform |
| 08/03/2023 | 123.88% | Goldman Sachs | $3.5 → $3 | Maintains | Neutral |
| 06/26/2023 | 86.57% | Morgan Stanley | $2.5 → $2.5 | Reiterates | Underweight → Underweight |
| 06/06/2023 | — | Raymond James | Upgrades | Underperform → Market Perform | |
| 05/04/2023 | 49.25% | B of A Securities | $4 → $2 | Maintains | Underperform |
| 05/04/2023 | 161.19% | Goldman Sachs | $4 → $3.5 | Maintains | Neutral |
| 05/03/2023 | 123.88% | Wells Fargo | $5 → $3 | Maintains | Equal-Weight |
| 03/13/2023 | 86.57% | Morgan Stanley | $6 → $2.5 | Maintains | Underweight |
| 02/08/2023 | 198.51% | Goldman Sachs | $6 → $4 | Maintains | Neutral |
| 02/08/2023 | 161.19% | Citigroup | $6.25 → $3.5 | Downgrades | Neutral → Sell |
| 02/01/2023 | 366.42% | Citigroup | $8 → $6.25 | Maintains | Neutral |
| 12/06/2022 | 347.76% | Goldman Sachs | → $6 | Reinstates | → Neutral |
| 11/03/2022 | 422.39% | JP Morgan | $10 → $7 | Maintains | Underweight |
| 11/03/2022 | 422.39% | UBS | $11 → $7 | Maintains | Neutral |
| 10/24/2022 | 497.01% | Morgan Stanley | $9.5 → $8 | Maintains | Underweight |
| 10/20/2022 | 347.76% | RBC Capital | $11 → $6 | Maintains | Sector Perform |
| 10/13/2022 | 497.01% | Citigroup | $11 → $8 | Maintains | Neutral |
| 10/05/2022 | 497.01% | Wells Fargo | → $8 | Downgrades | Overweight → Equal-Weight |
| 08/11/2022 | 720.9% | RBC Capital | $10 → $11 | Maintains | Sector Perform |
| 08/05/2022 | 646.27% | JP Morgan | → $10 | Reinstates | → Underweight |
| 08/23/2021 | 720.9% | Morgan Stanley | $12.1 → $11 | Maintains | Underweight |
| 05/20/2021 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 01/28/2021 | — | Morgan Stanley | Downgrades | Equal-Weight → Underweight | |
| 12/14/2020 | 802.99% | Morgan Stanley | $13.8 → $12.1 | Maintains | Equal-Weight |
What is the target price for Lumen Technologies (LUMN)?
The latest price target for Lumen Technologies (NYSE: LUMN) was reported by Goldman Sachs on November 9, 2023. The analyst firm set a price target for $1.50 expecting LUMN to rise to within 12 months (a possible 11.94% upside). 15 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Lumen Technologies (LUMN)?
The latest analyst rating for Lumen Technologies (NYSE: LUMN) was provided by Goldman Sachs, and Lumen Technologies maintained their neutral rating.
When is the next analyst rating going to be posted or updated for Lumen Technologies (LUMN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lumen Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lumen Technologies was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.
Is the Analyst Rating Lumen Technologies (LUMN) correct?
While ratings are subjective and will change, the latest Lumen Technologies (LUMN) rating was a maintained with a price target of $3.00 to $1.50. The current price Lumen Technologies (LUMN) is trading at is $1.34, which is out of the analyst's predicted range.